Skip to Content

E126 (Letrozole 2.5 mg)

Pill with imprint E126 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Qualitest Pharmaceuticals.

Letrozole is used in the treatment of breast cancer; breast cancer, adjuvant; breast cancer, metastatic and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for E126

Letrozole 2.5 mg E126

Letrozole

Imprint
E126
Strength
2.5 mg
Color
Yellow
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Aromatase inhibitors, Hormones/antineoplastics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Qualitest Pharmaceuticals
National Drug Code (NDC)
00603-4180
Inactive Ingredients
lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, corn starch, magnesium silicate, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "E126"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.